Selected article for: "adequately assess and logistic regression"
Author: Vargas-Vázquez, Arsenio; Bello-Chavolla, Omar Yaxmehen; Ortiz-Brizuela, Edgar; Campos-Muñoz, Alejandro; Mehta, Roopa; Villanueva-Reza, Marco; Bahena-López, Jessica Paola; Antonio-Villa, Neftali Eduardo; González-Lara, María Fernanda; Ponce de León, Alfredo; Sifuentes-Osornio, Jose; Aguilar-Salinas, Carlos Alberto
Title: Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection
  • Cord-id: 3dd7vmdp
  • Document date: 2021_2_16
    • ID: 3dd7vmdp
    Snippet: INTRODUCTION: Diabetes and hyperglycemia are risk factors for critical COVID-19 outcomes; however, the impact of pre-diabetes and previously unidentified cases of diabetes remains undefined. Here, we profiled hospitalized patients with undiagnosed type 2 diabetes and pre-diabetes to evaluate its impact on adverse COVID-19 outcomes. We also explored the role of de novo and intrahospital hyperglycemia in mediating critical COVID-19 outcomes. RESEARCH DESIGN AND METHODS: Prospective cohort of 317 h
    Document: INTRODUCTION: Diabetes and hyperglycemia are risk factors for critical COVID-19 outcomes; however, the impact of pre-diabetes and previously unidentified cases of diabetes remains undefined. Here, we profiled hospitalized patients with undiagnosed type 2 diabetes and pre-diabetes to evaluate its impact on adverse COVID-19 outcomes. We also explored the role of de novo and intrahospital hyperglycemia in mediating critical COVID-19 outcomes. RESEARCH DESIGN AND METHODS: Prospective cohort of 317 hospitalized COVID-19 cases from a Mexico City reference center. Type 2 diabetes was defined as previous diagnosis or treatment with diabetes medication, undiagnosed diabetes and pre-diabetes using glycosylated hemoglobin (HbA1c) American Diabetes Association (ADA) criteria and de novo or intrahospital hyperglycemia as fasting plasma glucose (FPG) ≥140 mg/dL. Logistic and Cox proportional regression models were used to model risk for COVID-19 outcomes. RESULTS: Overall, 159 cases (50.2%) had type 2 diabetes and 125 had pre-diabetes (39.4%), while 31.4% of patients with type 2 diabetes were previously undiagnosed. Among 20.0% of pre-diabetes cases and 6.1% of normal-range HbA1c had de novo hyperglycemia. FPG was the better predictor for critical COVID-19 compared with HbA1c. Undiagnosed type 2 diabetes (OR: 5.76, 95% CI 1.46 to 27.11) and pre-diabetes (OR: 4.15, 95% CI 1.29 to 16.75) conferred increased risk of severe COVID-19. De novo/intrahospital hyperglycemia predicted critical COVID-19 outcomes independent of diabetes status. CONCLUSIONS: Undiagnosed type 2 diabetes, pre-diabetes and de novo hyperglycemia are risk factors for critical COVID-19. HbA1c must be measured early to adequately assess individual risk considering the large rates of undiagnosed type 2 diabetes in Mexico.

    Search related documents:
    Co phrase search for related documents
    • accurate estimation and adaptive response: 1
    • accurate estimation and logistic regression: 1, 2, 3
    • accurate estimation and logistic regression analysis: 1
    • accurate estimation and logistic regression model: 1
    • accurate estimation and low prevalence: 1, 2
    • accurate estimation and lung disease: 1, 2
    • acute hyperglycemia and logistic regression: 1
    • acute hyperglycemia and lung disease: 1, 2
    • acute illness and adaptive response: 1, 2, 3, 4
    • acute illness and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute illness and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7
    • acute illness and logistic regression model: 1, 2, 3, 4, 5
    • acute illness and low prevalence: 1, 2, 3, 4, 5
    • acute illness and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute illness and lymphocyte index: 1, 2
    • adaptive response and logistic regression: 1, 2, 3, 4
    • adaptive response and logistic regression analysis: 1
    • adaptive response and lung disease: 1, 2, 3, 4, 5, 6, 7, 8
    • admission glucose level and logistic regression: 1, 2, 3, 4